E09.3493 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral

Name of the Condition

• Drug or Chemical Induced Diabetes Mellitus with Severe Nonproliferative Diabetic Retinopathy Without Macular Edema, Bilateral (ICD-10 Code: E09.3493)

Summary

Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral, is a condition where elevated blood sugar levels, caused by exposure to specific medications or chemicals, lead to advanced eye complications affecting both eyes. This form of diabetes is directly attributable to external factors that disrupt glucose metabolism, resulting in hyperglycemia and associated retinal damage. The retinopathy is classified as severe nonproliferative without macular edema, meaning it involves significant retinal changes without abnormal blood vessel growth and does not include swelling in the macula of either eye.

Causes

The condition is caused by exposure to drugs or chemicals that impair glucose regulation, leading to uncontrolled hyperglycemia. Common culprits include medications (e.g., glucocorticoids, antipsychotics, or diuretics) and toxins that reduce insulin secretion or increase insulin resistance. These substances trigger hyperglycemia, which, if untreated, progresses to severe nonproliferative diabetic retinopathy without macular edema due to damage to blood vessels in the retina of both eyes.

Risk Factors

• Use of medications known to affect glucose metabolism (e.g., steroids, antipsychotics, or diuretics)
• Exposure to chemicals or toxins that disrupt insulin function
• Prolonged hyperglycemia from drug or chemical exposure
• Pre-existing insulin resistance or impaired glucose tolerance
• Bilateral eye involvement increases risk of vision impairment

Symptoms

• Blurred or distorted vision in both eyes
• Difficulty seeing at night or in low light
• Floaters or spots in the visual field
• Reduced color perception
• Gradual vision loss without sudden changes
• No symptoms of macular edema (e.g., central vision swelling)

Diagnosis

Diagnosis involves a combination of clinical history, laboratory tests, and ophthalmic evaluation. A detailed medication or chemical exposure history is critical to confirm the induced nature of diabetes. Blood glucose and HbA1c tests assess hyperglycemia. Ophthalmic exams, including dilated retinal imaging (e.g., fundus photography or optical coherence tomography), identify severe nonproliferative retinopathy without macular edema. Bilateral involvement is confirmed through examination of both eyes.

Treatment Options

Treatment focuses on managing hyperglycemia and addressing retinal changes. Discontinuing or adjusting the causative drug/chemical is essential. Glycemic control via medication, insulin, or lifestyle changes is prioritized. Ophthalmic care may include laser therapy or anti-VEGF injections if retinopathy progresses. Regular monitoring of both eyes is necessary to detect worsening or complications.

Prognosis and Follow-Up

Prognosis depends on early intervention and glycemic control. With proper management, retinopathy may stabilize, but bilateral involvement increases the risk of permanent vision loss if untreated. Follow-up includes regular eye exams (every 3–6 months) and glucose monitoring. Long-term care focuses on preventing progression to proliferative retinopathy or macular edema.

Complications

• Bilateral vision impairment or blindness
• Progression to proliferative diabetic retinopathy
• Macular edema (if untreated)
• Increased risk of cataracts or glaucoma
• Cardiovascular complications from uncontrolled diabetes

Lifestyle & Prevention

• Avoid or limit exposure to known hyperglycemic drugs/chemicals
• Maintain strict glycemic control through diet, exercise, and medication
• Regular eye exams to detect early retinal changes
• Manage blood pressure and cholesterol to reduce retinopathy risk
• Quit smoking, as it exacerbates diabetic eye disease

When to Seek Professional Help

Seek immediate care if you experience sudden vision changes, increased floaters, or vision loss in either eye. Regular ophthalmic evaluations are recommended for those with drug-induced diabetes, especially if bilateral retinopathy is present. Prompt intervention can prevent irreversible damage.

Tips for Medical Coders

Document the bilateral nature of the retinopathy and confirm the absence of macular edema. Include details of the causative drug or chemical exposure to support the induced diabetes diagnosis. Ensure ophthalmic findings align with severe nonproliferative retinopathy criteria (e.g., extensive retinal hemorrhages, microaneurysms, or venous beading) without macular involvement. Use this code only when both eyes are affected and the retinopathy is severe nonproliferative without macular edema.